by A new study by Emory University suggests that psilocybin, the active connection in magical mushrooms, can extend its lifespan.
Scientists from the University of Medicine in Atlanta found that psilocybin increased cellular durability and improved the survival rates in old mice.
The study that was published in the magazine last week NatureDefined psilocybin as “naturally occurring psychedelic compound created by hallucinogenic fungi”.
The researchers found a growing interest in psilocybin for the treatment of psychiatric and neurodegenerative diseases. However, this study provides the first experimental proof that psilocin, its active form, promotes longevity in aged mice.
The study suggests that psilocybin can be a powerful anti-aging agent. Data show that it reduces oxidative stress, prevents DNA damage and can protect the telomer length, which all help to slow down the aging process.
A study is the first to experimentally show that its active form psilocin extends the lifespan in aged mice. (Getty Images)
The older white -haired mice even appeared after the treatment of younger and growing black hair.
“Psilocybin seems to slow down the” wear “that accompanies aging,” co-author of the study, Louise Hecker from Emory University, told Fox News Digital. “Mice and cells are healthier and live much longer.”
While the study indicates that this could also work for people, many more tests are required. Hecker told the outlet that the researchers have questions such as “What are the optimal dosage protocols for humans? What is the optimal age for the treatment of treatment for optimal advantages?”
“Is there an age, moreover, at what point when the treatment does not offer effectiveness?” She continued. “Are there potential damage or disadvantageous effects associated with long -term treatment? What are the mechanisms of their effect? All of these questions have to be tested strictly.”
Gabe Charambides, founder of the first legal psilocybin withdrawal of the USA in Oregon, described the results as “convincing”, but emphasized that human use requires stricter screening, preparation and security than for mice.
He added that those who may benefit the most from psilocybin therapy are people who feel “stuck” after major life events, such as: B. childhood trauma, divorce, loss of work or grief, or those who want to improve their mental health.
The study suggests that psilocybin can be a strong anti-aging agent and even saw some older mice of darker hair (AFP via Getty Images).
Charambides said that his retreat guests have reported physical problems such as chronic pain and migraines, even though no biological tests are carried out.
Ryan Moss from Filament Health, a Canadian natural psychedelic pharmaceutical development company, which was previously emphasized digitally that the use of psychedelics should be administered in a safe, controlled environment.
“Psychedelic experiences can sometimes have fear, hallucinations and paranoia,” said Moss. “Some patients who use traditional psychedelics have reported that he experienced unwanted cardiovascular events in clinical studies.”
He recommends that the participants of the clinical study are well prepared and closely monitored by trained experts.
